Back to Search
SETH JOHNSTON, PHARM.D
PHARM.D
Pharmacist
NPI: 1710645346Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PD11642(AR)
Research & Publications (20)
Enhancing the efficacy of hormonal agents with selected targeted agents.
PMID 19561004·Clin Breast Cancer·2009
6-review
A genomic island of the sulfate-reducing bacterium Desulfovibrio vulgaris Hildenborough promotes survival under stress conditions while decreasing the efficiency of anaerobic growth.
PMID 19077010·Environ Microbiol·2009
8-other
Tortuosity of arterioles and venules in quantifying plus disease.
PMID 19393518·J AAPOS·2009
4-observational
Teaching sound letter correspondence and consonant-vowel-consonant combinations to young children who use augmentative and alternative communication.
PMID 19444683·Augment Altern Commun·2009
5-case
Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling.
PMID 19233730·Lancet Neurol·2009
8-other
Vaccinia virus protein F12 associates with intracellular enveloped virions through an interaction with A36.
PMID 19052096·J Virol·2009
8-other
Comparison of fixed and gradual array when teaching sound-letter correspondence to two children with autism who use AAC.
PMID 19444684·Augment Altern Commun·2009
5-case
Resistance of Acanthamoeba cysts to disinfection in multiple contact lens solutions.
PMID 19403771·J Clin Microbiol·2009
7-preclinical
Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
PMID 18072254·Cancer·2008
8-other
Death after PEG: results of the National Confidential Enquiry into Patient Outcome and Death.
PMID 18329030·Gastrointest Endosc·2008
8-other
Clinical immunology review series: an approach to the patient with recurrent superficial abscesses.
PMID 18422735·Clin Exp Immunol·2008
6-review
Geometric calibration for a dual tube/detector micro-CT system.
PMID 18561657·Med Phys·2008
7-preclinical
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy.
PMID 17851757·Breast Cancer Res Treat·2008
3-trial
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy.
PMID 18212337·J Clin Oncol·2008
3-trial
Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) study.
PMID 18048860·Stroke·2008
4-observational
Enhancing endocrine response with novel targeted therapies: why have the clinical trials to date failed to deliver on the preclinical promise?
PMID 18072235·Cancer·2008
7-preclinical
Nonsurgical management of osteoarthritis in dogs.
PMID 18954692·Vet Clin North Am Small Anim Pract·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2412 E RACE AVE STE F
SEARCY, AR 72143 - Phone
- (501) 268-9400
Quick Facts
- NPI
- 1710645346
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile